1. Home
  2. MTNB vs NBY Comparison

MTNB vs NBY Comparison

Compare MTNB & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTNB
  • NBY
  • Stock Information
  • Founded
  • MTNB 2013
  • NBY 2000
  • Country
  • MTNB United States
  • NBY United States
  • Employees
  • MTNB N/A
  • NBY N/A
  • Industry
  • MTNB Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • MTNB Health Care
  • NBY
  • Exchange
  • MTNB Nasdaq
  • NBY Nasdaq
  • Market Cap
  • MTNB 3.6M
  • NBY 3.5M
  • IPO Year
  • MTNB N/A
  • NBY 2007
  • Fundamental
  • Price
  • MTNB $0.94
  • NBY $0.63
  • Analyst Decision
  • MTNB Hold
  • NBY Strong Buy
  • Analyst Count
  • MTNB 1
  • NBY 1
  • Target Price
  • MTNB N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • MTNB 376.6K
  • NBY 30.0K
  • Earning Date
  • MTNB 08-13-2025
  • NBY 08-12-2025
  • Dividend Yield
  • MTNB N/A
  • NBY N/A
  • EPS Growth
  • MTNB N/A
  • NBY N/A
  • EPS
  • MTNB N/A
  • NBY 0.57
  • Revenue
  • MTNB N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • MTNB N/A
  • NBY $23.91
  • Revenue Next Year
  • MTNB N/A
  • NBY $32.05
  • P/E Ratio
  • MTNB N/A
  • NBY $1.33
  • Revenue Growth
  • MTNB N/A
  • NBY 20.52
  • 52 Week Low
  • MTNB $0.47
  • NBY $0.36
  • 52 Week High
  • MTNB $9.60
  • NBY $2.45
  • Technical
  • Relative Strength Index (RSI)
  • MTNB 56.79
  • NBY 57.81
  • Support Level
  • MTNB $0.88
  • NBY $0.58
  • Resistance Level
  • MTNB $1.04
  • NBY $0.64
  • Average True Range (ATR)
  • MTNB 0.09
  • NBY 0.03
  • MACD
  • MTNB -0.01
  • NBY 0.00
  • Stochastic Oscillator
  • MTNB 30.17
  • NBY 78.71

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: